In conclusion, our study reported that E2F7 downregulated the expression of miR-199b, leading to the upregulation of the miR-199b target USP47 that stabilized MAPK, promoting colon cancer stem cell activity, thereby accelerating the development and progression of colon cancer (Figure 8). Here, E2F7 is linked to malignant colon neoplasm.